Implementation, efficacy and cost effectiveness of the unified protocol in a blended format for the transdiagnostic treatment of emotional disorders: a study protocol for a multicentre, randomised, superiority controlled trial in the Spanish National Health System

J Osma, Laura Martínez-García, Óscar Peris-Baquero, María Vicenta Navarro-Haro, Alberto González-Pérez, Carlos Suso-Ribera, J Osma, Laura Martínez-García, Óscar Peris-Baquero, María Vicenta Navarro-Haro, Alberto González-Pérez, Carlos Suso-Ribera

Abstract

Introduction: Emotional disorders (EDs) have become the most prevalent psychological disorders in the general population, which has boosted the economic burden associated with their management. Approximately half of the individuals do not receive adequate treatment. Consequently, finding solutions to deliver cost-effective treatments for EDs has become a key goal of today's clinical psychology. Blended treatments, a combination of face-to-face and online interventions, have emerged as a potential solution to the previous. The Unified Protocol for the Transdiagnostic Treatment of EDs (UP) might serve this purpose, as it can be applied to a variety of disorders simultaneously and its manualised format makes it suitable for blended interventions.

Methods and analysis: The study is a multicentre, randomised, superiority, clinical trial. Participants will be 310 individuals with a diagnosis of an ED. They will be randomised to a treatment as usual (individual cognitive behavioural therapy) or a UP condition in a blended format (face-to-face individual UP +online, app-based UP). Primary outcomes will be ED diagnostic criteria and depression and anxiety symptoms. Cost efficiency of the intervention, app usability, as well as opinion and confidence in the treatment will also be evaluated. Assessment points will include baseline and 3 months, 6 months and 12 months after UP treatment.

Ethics and dissemination: The study has received approvals by the Ethics Research Committee of Navarra, Castellón, Euskadi, Castilla y León, Extremadura, Lleida and Aragón. The study is currently under an approval process by the Ethics Research Committees of all the remaining collaborating centres. Outcomes will be disseminated through publication in peer-reviewed journals and presentations at international conference meetings.

Trial registration number: NCT04304911.

Keywords: anxiety disorders; depression & mood disorders; mental health; public health.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Study flow chart. TAU, treatment as usual; UP, the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders.

References

    1. Bullis JR, Boettcher H, Sauer‐Zavala S, et al. . What is an emotional disorder? a transdiagnostic mechanistic definition with implications for assessment, treatment, and prevention. Clin Psychol Sci Pract 2019;26:e12278. 10.1111/cpsp.12278
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5th edn. Arlington, VA, 2013.
    1. World Health Organization . Depression and other common mental disorders: global health estimates, 2017: 1–24.
    1. Ruiz-Rodríguez P, Cano-Vindel A, Muñoz Navarro R, et al. . Impacto económico Y carga de los trastornos mentales comunes en España: Una revisión sistemática Y crítica. Ansiedad y Estrés 2017;23:118–23. 10.1016/j.anyes.2017.10.003
    1. Cano-Vindel A, Muñoz-Navarro R, Wood CM, Wood JT M, et al. . Transdiagnostic cognitive behavioral therapy versus treatment as usual in adult patients with emotional disorders in the primary care setting (PsicAP study): protocol for a randomized controlled trial. JMIR Res Protoc 2016;5:e246. 10.2196/resprot.6351
    1. Barlow DH, Ellard KK, Fairholme CP. The unified protocol for transdiagnostic treatment of emotional disorders: client workbook. New York: Oxford University Press, 2011.
    1. Barlow DH, Farchione TJ, Fairholme CP. The unified protocol for transdiagnostic treatment of emotional disorders: therapist guide. New York: Oxford University Press, 2011.
    1. Brown TA, Barlow DH. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol Assess 2009;21:256–71. 10.1037/a0016608
    1. Brown TA, Campbell LA, Lehman CL, et al. . Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 2001;110:585–99. 10.1037/0021-843X.110.4.585
    1. McHugh RK, Murray HW, Barlow DH. Balancing fidelity and adaptation in the dissemination of empirically-supported treatments: the promise of transdiagnostic interventions. Behav Res Ther 2009;47:946–53. 10.1016/j.brat.2009.07.005
    1. Carlucci L, Saggino A, Balsamo M. On the efficacy of the unified protocol for transdiagnostic treatment of emotional disorders: a systematic review and meta-analysis. Clin Psychol Rev 2021;87:101999. 10.1016/j.cpr.2021.101999
    1. Cassiello-Robbins C, Southward MW, Tirpak JW, et al. . A systematic review of unified protocol applications with adult populations: facilitating widespread dissemination via adaptability. Clin Psychol Rev 2020;78:101852. 10.1016/j.cpr.2020.101852
    1. Sakiris N, Berle D. A systematic review and meta-analysis of the unified protocol as a transdiagnostic emotion regulation based intervention. Clin Psychol Rev 2019;72:101751. 10.1016/j.cpr.2019.101751
    1. Osma J, Suso-Ribera C, Peris-Baquero O. Eficacia del Protocolo Unificado en formato grupal para el tratamiento transdiagnóstico de los trastornos emocionales en unidades de salud mental públicas españolas. In: Osma J, ed. Aplicaciones del Protocolo Unificado para El Tratamiento Transdiagnóstico La Disregulación Emocional. Madrid: Alianza Editorial, 2019: 203–18.
    1. Osma J, Suso-Ribera C, Peris-Baquero Óscar, et al. . What format of treatment do patients with emotional disorders prefer and why? implications for public mental health settings and policies. PLoS One 2019;14:e0218117. 10.1371/journal.pone.0218117
    1. van Gemert-Pijnen JEWC, Nijland N, van Limburg M, et al. . A holistic framework to improve the uptake and impact of eHealth technologies. J Med Internet Res 2011;13:e111. 10.2196/jmir.1672
    1. Wentzel J, van der Vaart R, Bohlmeijer ET, et al. . Mixing online and face-to-face therapy: how to benefit from blended care in mental health care. JMIR Ment Health 2016;3:e9. 10.2196/mental.4534
    1. Leterme AC, Behal H, Demarty AL, et al. . A blended cognitive behavioral intervention for patients with adjustment disorder with anxiety: a randomized controlled trial. Internet Interv 2020;21:100329. 10.1016/j.invent.2020.100329
    1. Ly KH, Topooco N, Cederlund H, et al. . Smartphone-supported versus full behavioural activation for depression: a randomised controlled trial. PLoS One 2015;10:e0126559. 10.1371/journal.pone.0126559
    1. Erbe D, Eichert H-C, Riper H, et al. . Blending face-to-face and Internet-based interventions for the treatment of mental disorders in adults: systematic review. J Med Internet Res 2017;19:e306. 10.2196/jmir.6588
    1. Faul F, Erdfelder E, Lang A-G, et al. . G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–91. 10.3758/BF03193146
    1. Osma J, Quilez-Orden A, Suso-Ribera C, et al. . Psychometric properties and validation of the Spanish versions of the overall anxiety and depression severity and impairment scales. J Affect Disord 2019;252:9–18. 10.1016/j.jad.2019.03.063
    1. Barlow DH, Sauer-Zavala S, Farchione TJ. Protocolo unificado para el tratamiento transdiagnóstico de los trastornos emocionales. In: Manual del terapeuta (Jorge Osma Y Elena Crespo, TraD. 2nd edn. Madrid: Alianza Editorial, 20192019.
    1. Barlow DH, Sauer-Zavala S, Farchione TJ. Protocolo Unificado para el Tratamiento Transdiagnóstico de los Trastornos Emocionales. In: Manual del paciente (Jorge Osma Y Elena Crespo, TraD. 2nd edn. Madrid: Alianza Editorial, 20192019.
    1. Osma J, Suso-Ribera C, García-Palacios A, et al. . Efficacy of the unified protocol for the treatment of emotional disorders in the Spanish public mental health system using a group format: study protocol for a multicenter, randomized, non-inferiority controlled trial. Health Qual Life Outcomes 2018;16:46. 10.1186/s12955-018-0866-2
    1. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. In: Methodological issues & strategies in clinical research. Washington D.C: American Psychological Association, 1992: 631–48.
    1. Krueger C, Tian L. A comparison of the general linear mixed model and repeated measures ANOVA using a dataset with multiple missing data points. Biol Res Nurs 2004;6:151–7. 10.1177/1099800404267682
    1. Alvis N, Valenzuela MT. Los QALYs Y DALYs como indicadores sintéticos de salud. Rev. méd. Chile 2010;138:83–7. 10.4067/S0034-98872010001000005
    1. IBM Corp . Ibm SPSS statistics for windows, version 24.0. New York: IBM Corp, 2016.
    1. Muthén LK, Muthén BO. Mplus User’s Guide. 8 edn. Los Ángeles: CA: Muthén & Muthén, 2017.
    1. Piaggio G, Elbourne DR, Pocock SJ, et al. . Reporting of Noninferiority and equivalence randomized trials. JAMA 2012;308:2594. 10.1001/jama.2012.87802
    1. Ministerio de Justicia . Boletin Oficial del Estado, n°17 [BOE-A-2008-979], 2008. Available:
    1. Bentley KH, Gallagher MW, Carl JR, et al. . Development and validation of the overall depression severity and impairment scale. Psychol Assess 2014;26:815–30. 10.1037/a0036216
    1. Norman SB, Cissell SH, Means-Christensen AJ, et al. . Development and validation of an overall anxiety severity and impairment scale (OASIS). Depress Anxiety 2006;23:245–9. 10.1002/da.20182
    1. Sheehan DV, Lecrubier Y, Sheehan KH, et al. . The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22–33.
    1. Ferrando L, Bobes J, Gibert J. Detección Orientación Diagnóstica. In: Mini Entrevista Neuropsiquiátrica Internacional (mini international neuropsychiatric interview, mini, 2000.
    1. Rosellini AJ, Brown TA. The multidimensional emotional disorder inventory (MEDI): assessing transdiagnostic dimensions to validate a profile approach to emotional disorder classification. Psychol Assess 2019;31:59–72. 10.1037/pas0000649
    1. Brooks R, Group E. EuroQol: the current state of play. Health Policy 1996;37:53–72. 10.1016/0168-8510(96)00822-6
    1. Herdman M, Badia X, Berra S. El EuroQol-5D: Una alternativa sencilla para La medición de la calidad de vida relacionada Con La salud en atención primaria. Atención Primaria 2001;28:425–9. 10.1016/S0212-6567(01)70406-4
    1. Baer RA, Smith GT, Hopkins J, et al. . Using self-report assessment methods to explore facets of mindfulness. Assessment 2006;13:27–45. 10.1177/1073191105283504
    1. Cebolla A, García-Palacios A, Soler J, et al. . Psychometric properties of the Spanish validation of the five facets of mindfulness questionnaire (FFMQ). Eur. J. Psychiat. 2012;26:118–26. 10.4321/S0213-61632012000200005
    1. Gámez W, Chmielewski M, Kotov R, et al. . The brief experiential avoidance questionnaire: development and initial validation. Psychol Assess 2014;26:35–45. 10.1037/a0034473
    1. Vázquez-Morejón R, León Rubio JM, Martín Rodríguez A, Rubio JML, Rodríguez AM, et al. . Validation of a Spanish version of the Brief Experiential Avoidance Questionnaire (BEAQ) in clinical population. Psicothema 2019;31:335–40. 10.7334/psicothema2019.60
    1. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess 2004;26:41–54. 10.1023/B:JOBA.0000007455.08539.94
    1. Hervás G, Jódar R. Adaptación al castellano de la Escala de Dificultades en la Regulación Emocional [The Spanish version of the Difficulties in Emotion Regulation Scale]. Clin. salud 2008;19:139–56
    1. Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol 2003;85:348–62. 10.1037/0022-3514.85.2.348
    1. Cabello R, Salguero JM, Fernández-Berrocal P, et al. . A Spanish adaptation of the emotion regulation questionnaire. European Journal of Psychological Assessment 2013;29:234–40. 10.1027/1015-5759/a000150
    1. Brooke J. SUS—A quick and dirty usability scale usability. Eval. Ind 1996;189:4–7
    1. Sevilla-Gonzalez MDR, Moreno Loaeza L, Lazaro-Carrera LS, et al. . Spanish version of the system usability scale for the assessment of electronic tools: development and validation. JMIR Hum Factors 2020;7:e21161 10.2196/21161
    1. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000;31:73–86. 10.1016/S0005-7916(00)00012-4
    1. Baños Rivera RM, Botella G, Botella Arbona C. Un programa de tratamiento para Los Trastornos adaptativos. un estudio de caso Apunt. Psicol 2008;26:303–16.
    1. Beecham J, Knapp M. Client service receipt inventory (CSRI), 2018. Available:
    1. Vázquez-Barquero JL, Gaite L, Cuesta MJ. Spanish version of the CSRI: a mental health cost evaluation interview. Arch. Neurobiol 1997;60:171–84.
    1. Nord E. Cost-value analysis in health care: making sense out of QALYs. Cambridge University Press, 1999.
    1. Prieto L, Sacristán JA. Problems and solutions in calculating quality-adjusted life years (QALYs). Health Qual. Life Outcomes 2003;1. 10.1186/1477-7525-1-80
    1. Tracey TJ, Kokotovic AM. Factor structure of the working alliance inventory. Psychol Assess 1989;1:207–10. 10.1037/1040-3590.1.3.207
    1. Corbella S, Botella L, Gómez AM. Características psicométricas de la versión española del working alliance Inventory-Short (WAI-S). An. Psicol. Psychol 2011;27:298–301.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel